Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling

Nicholas R. Anderson(University of Alabama at Birmingham), Ravi Bhatia(City Of Hope National Medical Center)

Leukemia

December 22, 2022

10.1038/s41375-022-01798-5

Cited by 30

Related Papers

Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606

|Blood|2007|105

Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells

|Cancer Research|2008|99

Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells

|Blood|2007|59

Low c-Kit expression identifies primitive, therapy-resistant CML stem cells

|JCI Insight|2022|9